Home ›
Head and Neck Cancer Trials ›
NCT03545256
Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)
This is a single-center pilot study of open-label, non-randomized interventional research based on the outpatient management of 30 patients with T1-N0 or T2-N0 cancer in the oral cavity or oropharynx.
Trial Details
NCT ID NCT03545256
Phase NA
Sponsor University Hospital, Montpellier
Status RECRUITING
Cancer Type Head and Neck Cancer
Interventions outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity or oropharynx with lymph node search
Locations (sample) Montpellier, Hérault, France|43.61093,3.87635
Key Eligibility Criteria
Male or female over 18 years old with no upper age limit Patient (s) affiliated to a social security system, or beneficiary of such a system Patient information and informed consent signed by the patient Patient no longer participating in another trial since legal time
For full eligibility, visit ClinicalTrials.gov .